Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|October 6, 2020
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximabJamie S Lin, Daniel Y Wang, Omar Mamlouk, et al.
Kidney International Reports|May 25, 2026
Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes MellitusJuan J Cintrón-García, Maulinkumar Patel, Clark R Andersen, et al.
Journal for Immunotherapy of Cancer|July 29, 2020
Checkpoint inhibitor-related renal vasculitis and use of rituximabOmar Mamlouk, Jamie S Lin, Maen Abdelrahim, et al.
Clinical Kidney Journal|March 6, 2026
Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritisYazen Alasadi, Juan Cintron Garcia, Naszrin Arani, et al.
Cancers|November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor ResponseVishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.
Kidney International Reports|January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational EvidenceNada Youssef, Masroor Habeeb, Hong Chen, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
Pageof 3